Total Funding
30
1
Total FundingSeries D raised
Growth Score 30 in past quarter
-2 pts
Heat Score 1 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
759105
EyeTechCare developed the EyeOP1, an ultrasound device offering non-invasive treatments for refractory glaucoma.
- Bernard Chauvin: Independent DirectorPast Role: Neurotech, CEO
Laurent Farcy: Co - Founder & Director, Clinical & Regulatory AffairsPast Role: Medtronic, Clinical Project Leader (Sofradim)
About the Company
EyeTechCare has developed a new medical device called EyeOP1. This leading edge technology device is the result of several years of joint research with INSERM which has led to the development of a treatment method using High Intensity Focused Ultrasound (HIFU).
EyeOP1 is an ultrasound device which offers a non-invasive treatment for refractory
glaucoma. This new method is extremely accurate, simple and only takes one minute.